Why sourcing matters at scale
At the RDA of 14-18mg, the quality of a niacin supplement is nearly irrelevant — even a low-purity product delivers a negligible absolute amount of contaminants.
At 1-3 grams per day, you are consuming 100-200x more. Manufacturing contaminants, heavy metals, filler quality, and dissolution profiles all scale proportionally. A supplement that is 99% pure at 15mg delivers 0.15mg of impurities. The same product at 3g delivers 30mg of impurities daily.
Grading
USP (United States Pharmacopeia): Independently verified to meet standards for identity, strength, purity, and dissolution. USP-verified products carry the USP mark. This is the gold standard.
USP-grade (claimed): Manufacturer claims USP standards but has not undergone independent verification. Common and often legitimate, but unverified.
Food grade: Meets FDA requirements for food additives. Lower purity standards than pharmaceutical grade. May contain higher levels of heavy metals and processing residuals.
Reagent grade: Laboratory use. High purity but not tested for oral consumption safety.
Certificate of Analysis (COA)
A COA should specify:
- Identity: Confirms the product is nicotinic acid (not niacinamide)
- Purity: ≥99% for gram-scale use
- Heavy metals: Lead, arsenic, mercury, cadmium levels
- Microbial: Yeast, mold, E. coli, Salmonella testing
- Testing lab: Independent third-party, not manufacturer's own lab
Request the COA for the specific lot number you're purchasing. Reputable suppliers provide this without hesitation.
Form factors
Powder: Most economical for gram-scale dosing. Requires a scale for accurate measurement. Best for titration.
Tablets (immediate-release): Convenient, pre-measured. Ensure they are immediate-release — not "sustained-release," "extended-release," or "flush-free."
Capsules: Similar to tablets. Check for immediate-release formulation. Some capsules contain niacinamide mislabeled or marketed interchangeably with niacin.
The sustained-release warning
Sustained-release niacin formulations carry documented hepatotoxicity risk — 52% of patients in one comparative study developed liver toxicity markers. Immediate-release formulations showed 0% hepatotoxicity at equivalent doses. This is the single most important sourcing distinction.
What remains unknown
- Country-of-origin effects: Whether manufacturing origin (China, India, Europe, US) meaningfully affects purity for reputable suppliers with independent COA testing.
- Long-term contaminant accumulation: No studies track contaminant accumulation from daily gram-scale niacin supplementation over years.
- Dissolution profiles: Whether dissolution speed of immediate-release formulations varies enough between manufacturers to affect GPR109A activation patterns.